Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTsc with Dihydroartemisinin-piperaquine in Tanzanian School Children
NCT04245033Phase 4Completed
- Sponsor
- National Institute for Medical Research
- Start
- Jul 2020
- Primary completion
- May 2021
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in malaria, sponsored by National Institute for Medical Research. Started Jul 2020; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04245033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04245033.